Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Effect of antimicrobial stewardship with rapid MALDI-TOF identification and Vitek 2 antimicrobial susceptibility testing on hospitalization outcome.

Cavalieri SJ, Kwon S, Vivekanandan R, Ased S, Carroll C, Anthone J, Schmidt D, Baysden M, Destache CJ.

Diagn Microbiol Infect Dis. 2019 Jun 6. pii: S0732-8893(19)30304-9. doi: 10.1016/j.diagmicrobio.2019.05.020. [Epub ahead of print]

PMID:
31279585
2.

Whole genome mapping of the first reported case of KPC-2-positive Klebsiella pneumoniae ST258 in Nebraska.

Fowler RC, Scharn CR, Ali MA, Cavalieri SJ, Goering RV, Hanson ND.

Diagn Microbiol Infect Dis. 2014 Jul;79(3):384-6. doi: 10.1016/j.diagmicrobio.2014.03.023. Epub 2014 Apr 12.

PMID:
24813687
3.

Lemierre-like syndrome: a series of unique cases.

Hoffman MA, Birge ND, Chatterjee A, Cavalieri SJ, Akhtar JI, Cornish NE, Truemper EJ, Varman M.

Clin Pediatr (Phila). 2010 Sep;49(9):893-6. doi: 10.1177/0009922810366733. Epub 2010 May 19. No abstract available.

PMID:
20488807
4.

Comparison of DiaSorin and Bio-Rad test kits for the detection of hepatitis B virus total core and surface antibodies on the Bio-Rad Evolis.

Cavalieri SJ, Hrabovsky S, Jorgensen T.

Am J Clin Pathol. 2010 Jan;133(1):110-3. doi: 10.1309/AJCPHY8P2LOIKFBE.

PMID:
20023266
5.

Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.

Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, Cavalieri SJ.

Antimicrob Agents Chemother. 2008 Oct;52(10):3814-6. doi: 10.1128/AAC.00877-08. Epub 2008 Jul 28.

6.

Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.

Sanders CC, Peyret M, Moland ES, Cavalieri SJ, Shubert C, Thomson KS, Boeufgras JM, Sanders WE Jr.

J Clin Microbiol. 2001 Jul;39(7):2379-85.

7.

An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients.

Dominguez EA, Davis JC, Langnas AN, Winfield B, Cavalieri SJ, Rupp ME.

Liver Transpl Surg. 1997 Nov;3(6):586-90.

8.

Novel method for rapid identification of Nocardia species by detection of preformed enzymes.

Biehle JR, Cavalieri SJ, Felland T, Zimmer BL.

J Clin Microbiol. 1996 Jan;34(1):103-7.

9.

Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria.

Biehle JR, Cavalieri SJ, Saubolle MA, Getsinger LJ.

J Clin Microbiol. 1995 Jul;33(7):1760-4.

10.

Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis.

Cavalieri SJ, Biehle JR, Sanders WE Jr.

Antimicrob Agents Chemother. 1995 Jul;39(7):1542-5.

11.

Comparative evaluation of the E test for susceptibility testing of Nocardia species.

Biehle JR, Cavalieri SJ, Saubolle MA, Getsinger LJ.

Diagn Microbiol Infect Dis. 1994 Jun;19(2):101-10.

PMID:
7805354
12.

Influence of therapeutic plasmapheresis on elimination of ceftiaxone.

Bakken JS, Cavalieri SJ, Gangeness D, Kubat T, Pollack JR.

Antimicrob Agents Chemother. 1993 May;37(5):1171-3.

13.

In vitro susceptibility of Mycobacterium kansasii to clarithromycin.

Biehle J, Cavalieri SJ.

Antimicrob Agents Chemother. 1992 Sep;36(9):2039-41.

14.

Failure to adopt new interpretive criteria for ticarcillin-clavulanic acid could prove fatal.

Sanders CC, Sanders WE Jr, Thomson KS, Cavalieri SJ.

Antimicrob Agents Chemother. 1992 Jun;36(6):1343-4. No abstract available.

15.
16.

Influence of plasma exchange pheresis on plasma elimination of ceftriaxone.

Bakken JS, Cavalieri SJ, Gangeness D.

Antimicrob Agents Chemother. 1990 Jun;34(6):1276-7.

17.

Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strains.

Sanders CC, Cavalieri SJ.

J Clin Microbiol. 1990 Apr;28(4):830-1. No abstract available.

18.

Listeria monocytogenes peritonitis in a patient on continuous ambulatory peritoneal dialysis.

Allais JM, Cavalieri SJ, Bierman MH, Clark RB.

Nebr Med J. 1989 Oct;74(10):303-5.

PMID:
2510031
19.

Group A streptococcal peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.

Cavalieri SJ, Allais JM, Schlievert PM, Dworzack DL, Clark RB.

Am J Med. 1989 Feb;86(2):249-50. No abstract available.

PMID:
2643874
20.

Immune response to Escherichia coli alpha-hemolysin in patients.

Seetharama S, Cavalieri SJ, Snyder IS.

J Clin Microbiol. 1988 May;26(5):850-6.

21.

Purification of Escherichia coli alpha-hemolysin.

Bohach GA, Cavalieri SJ, Snyder IS.

Methods Enzymol. 1988;165:137-46, 399. No abstract available.

PMID:
3068483
22.
23.

Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity.

Cavalieri SJ, Bohach GA, Snyder IS.

Microbiol Rev. 1984 Dec;48(4):326-43. Review. No abstract available.

24.

In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.

Rudrik JT, Cavalieri SJ, Britt EM.

Antimicrob Agents Chemother. 1984 Jul;26(1):97-100.

25.

Rapid antimicrobial susceptibility testing of Gram-negative clinical isolates with the AutoMicrobic system.

Backes BA, Cavalieri SJ, Rudrik JT, Britt EM.

J Clin Microbiol. 1984 Jun;19(6):744-7.

26.
27.
28.

Cytotoxic activity of partially purified Escherichia coli alpha haemolysin.

Cavalieri SJ, Snyder IS.

J Med Microbiol. 1982 Feb;15(1):11-21.

PMID:
6815328
29.

The isolation of a dimer of gene 8 protein of bacteriophage fd.

Cavalieri SJ, Goldthwait DA, Neet KE.

J Mol Biol. 1976 Apr 25;102(4):713-22. No abstract available.

PMID:
940152
30.

Gene 5 protein of bacteriophage fd: a dimer which interacts co-operatively with DNA.

Cavalieri SJ, Neet KE, Goldthwait DA.

J Mol Biol. 1976 Apr 25;102(4):697-711. No abstract available.

PMID:
781261

Supplemental Content

Loading ...
Support Center